X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (56) 56
humans (50) 50
female (35) 35
male (29) 29
general tagging of cross-sectional technologies spanning over several sections of the ipc (24) 24
general tagging of new technological developments (24) 24
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (24) 24
technologies or applications for mitigation or adaptation againstclimate change (24) 24
calculating (18) 18
computing (18) 18
counting (18) 18
electric digital data processing (18) 18
physics (18) 18
middle aged (17) 17
climate change mitigation technologies in the production orprocessing of goods (16) 16
child (15) 15
adult (14) 14
risk factors (14) 14
aged (13) 13
children (13) 13
hypertension (13) 13
peripheral vascular disease (13) 13
blood pressure (12) 12
obesity (12) 12
analysis (10) 10
cancer (10) 10
biochemistry (9) 9
care and treatment (9) 9
research (9) 9
adolescents (8) 8
animals (8) 8
beer (8) 8
chemistry (8) 8
compositions thereof (8) 8
culture media (8) 8
disease (8) 8
enzymes (8) 8
enzymology (8) 8
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (8) 8
metallurgy (8) 8
microbiology (8) 8
microorganisms or enzymes (8) 8
mutation or genetic engineering (8) 8
oncology (8) 8
propagating, preserving or maintaining microorganisms (8) 8
reduction of greenhouse gas [ghg] emissions, related to energygeneration, transmission or distribution (8) 8
spirits (8) 8
treatment outcome (8) 8
vinegar (8) 8
wine (8) 8
adolescent (7) 7
child, preschool (7) 7
cohort studies (7) 7
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (7) 7
hematology (7) 7
hypertension - physiopathology (7) 7
medicine (7) 7
overweight (7) 7
prognosis (7) 7
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (7) 7
blood-pressure (6) 6
health aspects (6) 6
hypertension - epidemiology (6) 6
information and communication technology [ict] specially adaptedfor specific application fields (6) 6
investigating or analysing materials by determining theirchemical or physical properties (6) 6
leukemia (6) 6
measuring (6) 6
medicine, research & experimental (6) 6
prevalence (6) 6
prospective studies (6) 6
recurrence (6) 6
reproducibility of results (6) 6
technologies for adaptation to climate change (6) 6
testing (6) 6
transplantation (6) 6
waist circumference (6) 6
aged, 80 and over (5) 5
body mass index (5) 5
cross-sectional studies (5) 5
echocardiography (5) 5
follow-up studies (5) 5
incidence (5) 5
insulin-resistance (5) 5
metabolic syndrome (5) 5
mice (5) 5
public, environmental & occupational health (5) 5
radiology, nuclear medicine & medical imaging (5) 5
statistics & probability (5) 5
abridged index medicus (4) 4
algorithms (4) 4
breast cancer (4) 4
cardiovascular risk (4) 4
chronic myeloid leukemia (4) 4
complications and side effects (4) 4
computer simulation (4) 4
crude incidence (4) 4
development and progression (4) 4
disease-free survival (4) 4
epidemiology (4) 4
follow-up (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 2014, Volume 106, Issue 2, pp. djt378 - djt378
Journal Article
Nature Genetics, ISSN 1061-4036, 01/2013, Volume 45, Issue 1, pp. 18 - 24
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2011, Volume 103, Issue 7, pp. 553 - 561
Background Imatinib slows development of chronic myeloid leukemia (CML). However, available information on morbidity and mortality is largely based on... 
CHRONIC MYELOGENOUS LEUKEMIA | MESYLATE | RESPONSES | INTERFERON | THERAPY | ONCOLOGY | RESISTANCE | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | POSITIVE LEUKEMIAS | TRANSPLANTATION | Piperazines - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Time Factors | Antineoplastic Agents - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Polymerase Chain Reaction | Adult | Female | Odds Ratio | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Drug Administration Schedule | Pyrimidines - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Benzamides | Development and progression | Care and treatment | Chronic myeloid leukemia | Research | Drug therapy | Patient outcomes | Cytogenetics | Side effects | Leukemia | Mortality | Edema | Imatinib | Statistical analysis | Sex | Clinical trials | Diarrhea | Muscles | Survival | Morbidity | Hemopoiesis | Philadelphia chromosome | Tendons | Polymerase chain reaction | Asthenia | Remission | Ligaments | Index Medicus
Journal Article
Pediatrics, ISSN 0031-4005, 07/2013, Volume 132, Issue 1, pp. e93 - e99
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 1, pp. e16406 - e16406
Orexins are neuro-modulatory peptides involved in the control of diverse physiological functions through interaction with two receptors, orexin-1 (OX1R) and... 
CEREBRAL BLOOD-VOLUME | SLEEP | ACTIVATION | PHARMACOLOGICAL MRI | CONDITIONED PLACE PREFERENCE | MULTIDISCIPLINARY SCIENCES | DRUG DISCOVERY | NEURONS | RAT-BRAIN | KNOCKOUT MICE | REWARD | Amphetamine - pharmacology | Receptors, Neuropeptide - antagonists & inhibitors | Rats | Orexin Receptors | Behavior, Animal | Activity Cycles - physiology | Magnetic Resonance Imaging | Animals | Motivation - physiology | Piperidines - pharmacology | Aminopyridines - pharmacology | Receptors, G-Protein-Coupled - antagonists & inhibitors | Brain Mapping | Dioxanes - pharmacology | Phenylurea Compounds - pharmacology | Reward | Physiological aspects | Cocaine | Sleep | Magnetic resonance imaging | Neuroimaging | Cluster analysis | Ecstasy | Drugs | Brain | Drug abuse | Animal models | Nuclear magnetic resonance--NMR | Peptides | Selectivity | Blood | Receptors | Rodents | Arousal | Neostriatum | Functional magnetic resonance imaging | Reinforcement | Physiology | Conditioning | Drug dosages | Sleep and wakefulness | Brain architecture | Statistical analysis | Orexins | Research & development--R&D | Cortex | Brain mapping | Metabolism | Anatomy | Substrates | Studies | Contrast agents | Brain research | Amphetamine | Psychopharmacology | Resonance | Nanotechnology | Index Medicus | Research & development | Nuclear magnetic resonance | R&D | NMR
Journal Article
Epidemiology Biostatistics and Public Health, 2018, Volume 15, Issue 3
Background: To summarize the survival experience of patients waiting for heart transplant and to compare it with the post-transplant survival it is not... 
Clock-back time scale | Non-parametric estimator | Heart transplant | Illness-death model | Time-dependent treatment
Journal Article
Surgical Endoscopy, ISSN 0930-2794, 3/2013, Volume 27, Issue 3, pp. 832 - 842
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 08/2012, Volume 37, Issue 9, pp. 1999 - 2011
Orexins (OX) and their receptors (OXR) modulate feeding, arousal, stress, and drug abuse. Neural systems that motivate and reinforce drug abuse may also... 
orexin-2 receptor antagonist | female rats | compulsive food consumption | orexin-1 receptor antagonist | binge eating | INDUCED REINSTATEMENT | PSYCHIATRY | SYNAPTIC PLASTICITY | NEUROSCIENCES | ADDICTION | ANTAGONIST SB-334867 | CORTICOTROPIN-RELEASING-FACTOR | MESSENGER-RNA | DIETARY RESTRAINT | DISORDER | DOPAMINE | PHARMACOLOGY & PHARMACY | BRAIN STRESS | Eating - psychology | Intracellular Signaling Peptides and Proteins - pharmacology | Bulimia - psychology | Bulimia - drug therapy | Male | Receptors, G-Protein-Coupled - agonists | Eating - physiology | Bulimia - metabolism | Compulsive Behavior - drug therapy | Fructose - pharmacology | Neuropeptides - pharmacology | Receptors, Neuropeptide - agonists | Female | Tumor Cells, Cultured | Receptors, Neuropeptide - physiology | Receptors, G-Protein-Coupled - physiology | Compulsive Behavior - psychology | Orexins | Receptors, Neuropeptide - antagonists & inhibitors | Rats | Orexin Receptors | Rats, Sprague-Dawley | Fructose - therapeutic use | Eating - drug effects | Fructose - analogs & derivatives | Reinforcement Schedule | Animals | Receptors, G-Protein-Coupled - antagonists & inhibitors | Sex Factors | Index Medicus | Drug abuse | Eating disorders | Stress | Feeding | Sleep | Food availability | Food intake | Orexin receptors | Arousal | Food consumption | Pharmacokinetics | topiramate | metabolic disorders | animal models | psychopharmacology | behavioral science | eating | Original
Journal Article